University of Cambridge
Dominik GreweResearcher
Isomorphic Labs
Principal Software Engineer
via Isomorphic Labs
Researcher
Miles Congreve
MC
Chief Scientific Officer at Isomorphic Labs
Congreve is a medicinal chemist who pioneered fragment-based drug discovery at Astex and structure-based design for GPCR targets at Sosei Heptares, and is co-inventor of the breast-cancer drug Kisqali (ribociclib). He is Chief Scientific Officer at Isomorphic Labs and was named to the 2025 TIME 100 AI list.
See something inaccurate or outdated?
Background
Current role
Chief Scientific OfficerIsomorphic Labs
Isomorphic LabsPreviously
About this data
Work and education history is primarily focused on AI-relevant roles and may not be comprehensive.
Last editorial review: August 15, 2026Citation Trend
2 snapshots30,532citations as of Jun 15, '26+9,605 since Aug 25, '25
For today’s citation count and citations per paper, visit Google Scholar.